Noninvasive brain stimulation (NIBS) is a painless and safe method used to improve quality of life and reduce the effects of issues related to speaking, swallowing, movement, cognition, and other functions. It can be achieved by stimulating the damaged area of the brain to restore affected function or compensating for the loss of function. Combining NIBS with individualized, task-specific, intense rehabilitation can lead to greater improvements in function than rehabilitation alone. A unique clinical program combines NIBS with intensive neuro-rehabilitation, with participants participating in sessions five days per week for three weeks. Therapy could include physical therapy, occupational therapy, and/or speech therapy. The brain stimulation technician and therapy team will administer standardized tests throughout the program, which will track progress and compare function from the beginning to the end. Test scores will be entered into the patient’s medical record. There are several ways to stimulate the brain externally, including transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). These methods provide critical insight into the effectiveness of the noninvasive brain stimulation program for the treatment of the condition.
Neuronal plasticity, the brain’s ability to adapt to environmental changes, can be achieved through noninvasive brain stimulation (NIBS) techniques like transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), random noise stimulation (RNS), transcranial ultrasound stimulation (TUS), vagus nerve stimulation (VNS), and galvanic vestibular stimulation (GVS). These techniques can induce plasticity at the system level, examine brain circuit neurophysiology, and potentially treat psychiatric and neurological disorders. Further research is needed to expand NIBS’s clinical utility and optimize neuromodulation-induced benefits.
Download Your Free PDF Sample: Unlock Key Market Insights @ https://cognizancemarketresearch.com/request/non-invasive-brain-stimulation-system-market/
Global Non-invasive Brain Stimulation System Market– Competitive Insight
In May 2023 Neuralink, a neurotech startup, received FDA approval for its first-in-human clinical study, aiming to help patients with severe paralysis regain communication using neural signals.
In August 2023, Tulasi Healthcare, a Gurugram-based company, introduced deep transcranial magnetic stimulation (TMS) therapy services to help individuals with treatment-resistant depression find relief and hope.
In October 2023 West Virginia University joins the BRAIN Center to advance neurological disorder technology, serving as a core clinical testing site for improved care and rehabilitation.
Some of the Key Players in the Global Non-invasive Brain Stimulation System Market Include –
- Brainbox Ltd.
- BrainsWay
- eNeura Inc.
- Flow Neuroscience
- Magnus Medical, Inc.
- Magstim
- MagVenture
- NeoSync, Inc. (Wave Neuroscience, Inc.)
- NeuraLace
- Neurocare Group AG
- NeuroMetrix
- Neuronetics
- Soterix Medical, Inc.
Global Non-invasive Brain Stimulation System Market– Growth Drivers
The global non-invasive brain stimulation system market is expanding due to factors such as healthcare infrastructure, government initiatives, neuroscience interest, mental health treatment demand, technology advancements, and research and development investments. Neurological conditions like depression, epilepsy, Parkinson’s disease, and chronic pain are also driving the market growth. The increasing prevalence of Parkinson’s disorder, a multi-symptomatic neurodegenerative disorder, and the aging population are driving the adoption of non-invasive brain stimulation procedures. Technological advancements, such as materials, manufacturing processes, and digital technologies, are enhancing the efficiency and effectiveness of these products and services. The increasing demand for these products and services is driven by factors like population growth, urbanization, and evolving consumer preferences. Government policies, regulations, and incentives, such as subsidies for renewable energy projects and carbon pricing mechanisms, stimulate market growth. Environmental awareness and the need to reduce carbon emissions fuel the adoption of eco-friendly and renewable solutions. Cost reductions in production and installation costs, driven by economies of scale, technological advancements, and intensified competition, enhance affordability and accessibility. Overall, the non-invasive brain stimulation system market is expected to continue growing due to these factors.
Global Non-invasive Brain Stimulation System Market– Restraints
The non-invasive brain stimulation market faces several challenges, including lack of awareness, high initial investment, intermittency and reliability issues, infrastructure limitations, policy uncertainty, competition from alternative technologies, and supply chain disruptions. The lack of awareness in developing countries and the increasing popularity of electroconvulsive therapy are major restraints. The high upfront investment required for developing and installing solutions, particularly for large-scale projects, is a significant barrier to market growth. Challenges related to intermittency and reliability, particularly in regions with erratic weather patterns, pose challenges. Infrastructure limitations, such as grid upgrades and storage facilities, are also significant barriers to market growth. Policy uncertainty, such as fluctuations in subsidies or tax incentives, introduces instability for investors and potentially impedes market growth. Alternative technologies like fossil fuels and nuclear energy also pose significant competition. Supply chain disruptions, such as shortages of critical materials or components, can disrupt the availability and pricing of non-invasive brain stimulation solutions, impacting market growth.
Download Free PDF: Sample Our Market Research @ https://cognizancemarketresearch.com/request/non-invasive-brain-stimulation-system-market/
Global Non-invasive Brain Stimulation System Market– Opportunities
The market for non-invasive brain stimulation systems is anticipated to grow as a result of sophisticated healthcare infrastructure and technology developments. Neurological conditions such as epilepsy, depression, stroke, Parkinson’s disease, and chronic pain are being treated with these technologies. These cutting-edge facilities are projected to drive market growth. For stakeholders to make well-informed decisions, market indicators like ambulatory surgery centers, hospitals, and clinics are essential. The Non-invasive Brain Stimulation System market is expected to experience exponential growth due to technological advancements, increased awareness, and adoption rates across diverse demographics. Strategic investments, research and development initiatives, and supportive regulatory frameworks are driving this growth. With a commitment to innovation and a trajectory toward sustained growth, the market presents opportunities for stakeholders to capitalize on this burgeoning sector. As scientists continue to find cutting-edge medications for the treatment of Parkinson’s disease, the market is anticipated to grow even more as a result of the FDA’s rising medicinal approvals.
Global Non-invasive Brain Stimulation System Market– Geographical Insight
For the foreseeable future, North America is anticipated to control the market. This is caused by several things, including the existence of a well-established healthcare system, an increased emphasis on R&D, rising healthcare costs, the creation of cutting-edge technologies, and the quickening pace of neuroscience research.
Because more people are receiving mental health treatments, the healthcare industry is adopting new technologies at a faster rate, and people are becoming more aware of modern therapies, the US market is expanding rapidly in the region. Moreover, non-invasive brain stimulation becomes necessary due to the rising incidence of depression and Parkinson’s disease, which propels the market’s expansion. More than a million Americans are diagnosed with Parkinson’s disease each year, and the number of Americans living with the disease is estimated to be close to ten times the finding and is increasing day by day.
Global Non-invasive Brain Stimulation System Market– Key Development
- In August 2023, Cleveland Clinic researchers conducted a first-in-human trial on deep brain stimulation for post-stroke rehabilitation patients, revealing its safety and feasibility in targeting the dentate nucleus.
- In July 2023, The Indian Institute of Technology (IIT) Kanpur initiated the ‘Jay Pullur neuroscience initiative’ to enhance its neuroscience research infrastructure.
- In October 2023, Butterfly Network and Forest Neurotech signed a five-year co-development agreement for Next-generation brain-computer interfaces using ultrasound-on-chip technology.